- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Omni Med
Total 7929 results
-
EMD SeronoCompletedOvarian CancerUnited States
-
EMD SeronoTerminated
-
EMD SeronoTerminatedMetastatic Colorectal CancerItaly, Spain, Belgium
-
Meda PharmaceuticalsCompletedSeasonal Allergic RhinitisUnited States
-
EMD SeronoCompletedMultiple SclerosisItaly, Russian Federation, United States, Argentina, Venezuela, Canada, Tunisia, France
-
Meda PharmaceuticalsCompletedAllergic RhinitisUnited States
-
EMD SeronoCompletedInfertile Women Undergoing Assisted Reproductive Technology (ART)
-
EMD SeronoCompletedHuman Immunodeficiency Virus Infections | Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)
-
EMD SeronoCompleted
-
EMD SeronoCompleted12-week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis.Multiple SclerosisUnited States, Canada, Germany, Italy, Spain, Sweden
-
EMD SeronoTerminatedArthritis, PsoriaticUnited States, Canada
-
EMD SeronoCompletedHIV Infections | HIV Wasting Syndrome
-
EMD SeronoTerminatedHaematological MalignanciesItaly, United States, Switzerland, Belgium, Germany
-
EMD SeronoCompletedMultiple SclerosisUnited States
-
EMD SeronoCompletedMultiple SclerosisUnited States
-
EMD SeronoWithdrawnRelapsing-Remitting Multiple Sclerosis
-
Meda PharmaceuticalsCompletedSeasonal Allergic RhinitisUnited States
-
Meda PharmaceuticalsCompletedSeasonal Allergic RhinitisUnited States
-
Meda PharmaceuticalsCompletedSeasonal Allergic RhinitisUnited States
-
Meda PharmaceuticalsCompletedChronic Allergic Rhinitis | Nonallergic RhinitisUnited States
-
Medy-ToxCompletedAgingKorea, Republic of
-
Medy-ToxCompletedPharmacokinetic/Pharmacodynamic Characteristics and Safety/Tolerability of MT921 in Healthy SubjectsHealthy VolunteersKorea, Republic of
-
Medy-ToxCompletedPostoperative Adhesion of UterusKorea, Republic of
-
Medy-ToxCompletedPenile EnhancementKorea, Republic of
-
Medy-ToxCompletedPenile Enhancement | Penile Girth EnhancementKorea, Republic of
-
Medy-ToxCompletedOverweightKorea, Republic of
-
Medy-ToxUnknownOveractive BladderKorea, Republic of
-
Medy-ToxUnknownGlabellar Frown LinesKorea, Republic of
-
EMD SeronoCompleted
-
Medy-ToxCompletedGlabellar Frown Lines
-
Medy-ToxCompletedSpasticity, Muscle
-
Medy-ToxCompletedCervical Dystonia
-
Medy-ToxCompletedGlabella Line SeverityKorea, Republic of
-
Medy-ToxCompletedHypertrophy of Masseter MuscleKorea, Republic of
-
Medy-ToxCompletedHyperhidrosis | Anhidrotic AreaKorea, Republic of
-
Medy-ToxCompletedPenile EnhancementKorea, Republic of
-
EMD SeronoCompletedSolid TumorUnited States
-
EMD SeronoCompletedHIV Infections | LipodystrophyUnited States, Canada
-
EMD SeronoCompleted
-
EMD SeronoWithdrawn
-
Medy-ToxCompleted
-
Medy-ToxCompleted
-
EMD SeronoTerminatedMultiple SclerosisUnited States
-
EMD SeronoTerminatedCarcinoma, Non-Small-Cell LungUnited States, Germany
-
EMD SeronoTerminatedRelapsing Remitting Multiple SclerosisUnited States, Croatia, Bulgaria, Czech Republic, Italy, Mexico, Russian Federation, South Africa, Spain, Turkey, Hungary, Poland, Ukraine, Finland, United Kingdom, Greece, Serbia
-
Medy-ToxCompletedNasolabial FoldKorea, Republic of
-
Meda PharmaceuticalsCompletedPerennial Allergic RhinitisUnited States
-
EMD SeronoTerminated
-
Medy-ToxCompleted